Compare SELF & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SELF | GNTA |
|---|---|---|
| Founded | 1983 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.3M | 34.0M |
| IPO Year | 1997 | N/A |
| Metric | SELF | GNTA |
|---|---|---|
| Price | $5.10 | $0.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.6K | ★ 53.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.73% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $12,530,280.00 | N/A |
| Revenue This Year | $1.59 | N/A |
| Revenue Next Year | $1.62 | N/A |
| P/E Ratio | $34.00 | ★ N/A |
| Revenue Growth | ★ 2.79 | N/A |
| 52 Week Low | $4.73 | $0.71 |
| 52 Week High | $5.83 | $10.00 |
| Indicator | SELF | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 50.69 | 39.45 |
| Support Level | $4.92 | $0.71 |
| Resistance Level | $5.12 | $1.70 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 40.72 | 17.75 |
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.